Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 8 of 1714:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Gene Compound Assay Inh Ic50 Ki View
sodium channel associated protein 2 CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type III, beta CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type I, alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type IX, alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
sodium channel, voltage-gated, type VII, alpha CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
amiloride-sensitive cation channel 5, intestinal CLEMASTINE Sodium Channel, Site 2 100% .849uM .774uM View
adrenergic receptor, alpha 2b YOHIMBINE Adrenergic alpha2B 100% .017uM .007947uM View
melanocortin 5 receptor COLISTIN Melanocortin MC5 100% .266uM .249uM View
Protein-tyrosine kinase, Fyn COLISTIN Protein Tyrosine Kinase, Fyn 100% .959uM NoneNone View
Cytochrom P450-1A2 monooxygenase 1-BENZYLIMIDAZOLE CYP450-1A2 Inhibition 100% .2uM NoneNone View
prostaglandin-endoperoxide synthase 1 ZOMEPIRAC Cyclooxygenase COX-1 100% .017uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) ZOMEPIRAC Cyclooxygenase COX-1 100% .017uM NoneNone View
cholinergic receptor, muscarinic 4 TROPICAMIDE Muscarinic M4 100% .025uM .003483uM View
adrenergic receptor, alpha 1a CHLORPROMAZINE Adrenergic alpha1A 100% .008538uM .003456uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 AMIODARONE Dopamine Transporter 100% 2.505uM 1.99uM View
opioid receptor, sigma 1 AMIODARONE Sigma1 100% .097uM .041uM View
5-hydroxytryptamine (serotonin) receptor 2B AMIODARONE Serotonin 5-HT2B 100% .923uM .587uM View
sodium channel, voltage-gated, type IV, beta AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel associated protein 1 AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel associated protein 2 AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type III, beta AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type I, alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type IX, alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type VII, alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
amiloride-sensitive cation channel 5, intestinal AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type III, beta AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type XI, alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type I, beta AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type 10, alpha polypeptide AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type IV, alpha polypeptide AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type V, alpha polypeptide AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type II, beta AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, nonvoltage-gated 1 alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, nonvoltage-gated 1 gamma AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, nonvoltage-gated 1 beta AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type XI, alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, nonvoltage-gated 1, gamma AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, nonvoltage-gated 1, delta AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, nonvoltage-gated 1 alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type X, alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type IX, alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage gated, type VIII, alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type VII, alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type IV, beta AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type IV, alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type III, alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type II, beta AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type II, alpha 2 AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type I, beta AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
sodium channel, voltage-gated, type I, alpha AMIODARONE Sodium Channel, Site 2 100% .663uM .595uM View
dopamine receptor D3 AMIODARONE Dopamine D3 100% 1.208uM .41uM View
opioid receptor, delta 1 CLOTRIMAZOLE Opiate delta 100% 4.978uM 1.755uM View
adrenergic receptor, alpha 1d (Non-specific probe) CHLORPROMAZINE Adrenergic alpha1D 100% .003991uM .001962uM View
adrenergic receptor, alpha 2b CHLORPROMAZINE Adrenergic alpha2B 100% .026uM .012uM View
dopamine receptor D3 CHLORPROMAZINE Dopamine D3 100% .012uM .004205uM View
cholinergic receptor, muscarinic 5 CHLORPROMAZINE Muscarinic M5 100% .025uM .018uM View
5-hydroxytryptamine (serotonin) receptor 2C CHLORPROMAZINE Serotonin 5-HT2C 100% .005235uM .002742uM View
arachidonate 15-lipoxygenase PHENOTHIAZINE Lipoxygenase 15-LO 100% 4.643uM NoneNone View
arachidonate 15-lipoxygenase, second type PYROGALLOL Lipoxygenase 15-LO 100% 2.114uM NoneNone View
arachidonate 15-lipoxygenase PYROGALLOL Lipoxygenase 15-LO 100% 2.114uM NoneNone View
arachidonate 15-lipoxygenase PYROGALLOL Lipoxygenase 15-LO 100% 2.114uM NoneNone View
monoamine oxidase A PHENOTHIAZINE Monoamine Oxidase MAOA 100% .592uM NoneNone View
monoamine oxidase A PHENOTHIAZINE Monoamine Oxidase MAOA 100% .592uM NoneNone View
sodium channel, voltage-gated, type IV, beta BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel associated protein 1 BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
adenosine A1 receptor ZIDOVUDINE Adenosine A1 12% NoneNone NoneNone View
sodium channel associated protein 2 BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type III, beta BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type I, alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type IX, alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type VII, alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
amiloride-sensitive cation channel 5, intestinal BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type III, beta BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type XI, alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type I, beta BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type 10, alpha polypeptide BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type IV, alpha polypeptide BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type V, alpha polypeptide BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type II, beta BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, nonvoltage-gated 1 alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, nonvoltage-gated 1 gamma BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, nonvoltage-gated 1 beta BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type XI, alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, nonvoltage-gated 1, gamma BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, nonvoltage-gated 1, gamma U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, nonvoltage-gated 1, delta U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, nonvoltage-gated 1 alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type X, alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type IX, alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage gated, type VIII, alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type VII, alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type IV, beta U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type IV, alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type III, alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type II, beta U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type II, alpha 2 U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type I, beta U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
sodium channel, voltage-gated, type I, alpha U-78517F Sodium Channel, Site 2 100% 3.549uM 3.182uM View
adrenergic receptor, alpha 1b CHLORPROMAZINE Adrenergic alpha1B 100% .008966uM .004963uM View
adrenergic receptor, beta 3 CLOTRIMAZOLE Adrenergic beta3 100% 7.208uM 5.406uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 CLOTRIMAZOLE Dopamine Transporter 100% 5.581uM 4.434uM View
cholinergic receptor, muscarinic 3 CLOTRIMAZOLE Muscarinic M3 100% 9.928uM 2.104uM View
opioid receptor, kappa 1 CLOTRIMAZOLE Opiate kappa 100% 6.303uM 2.521uM View
adrenergic receptor, alpha 2b CLOTRIMAZOLE Adrenergic alpha2B 100% 8.159uM 3.725uM View
prostaglandin-endoperoxide synthase 1 IBUPROFEN Cyclooxygenase COX-1 100% .212uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) IBUPROFEN Cyclooxygenase COX-1 100% .212uM NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit FLUOXETINE Calcium Channel Type L, Benzothiazepine 100% .827uM .736uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit FLUOXETINE Calcium Channel Type L, Benzothiazepine 100% .827uM .736uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit FLUOXETINE Calcium Channel Type L, Benzothiazepine 100% .827uM .736uM View
calcium channel, voltage-dependent, beta 1 subunit FLUOXETINE Calcium Channel Type L, Benzothiazepine 100% .827uM .736uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit FLUOXETINE Calcium Channel Type L, Benzothiazepine 100% .827uM .736uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit FLUOXETINE Calcium Channel Type L, Benzothiazepine 100% .827uM .736uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 FLUOXETINE Calcium Channel Type L, Benzothiazepine 100% .827uM .736uM View
adrenergic receptor, alpha 2b FLUPHENAZINE Adrenergic alpha2B 100% .029uM .013uM View
opioid receptor, sigma 1 FLUPHENAZINE Sigma1 100% .02uM .008575uM View
histamine receptor H 1 FLUPHENAZINE Histamine H1, Central 100% .04uM .004662uM View
dopamine receptor 2 FLUPHENAZINE Dopamine D2L 100% .001616uM .000539uM View
5-hydroxytryptamine receptor 6 FLUPHENAZINE Serotonin 5-HT6 100% .052uM .024uM View
sodium channel, voltage-gated, type IV, beta FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel associated protein 1 FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel associated protein 2 FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type III, beta FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type I, alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type IX, alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type VII, alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
amiloride-sensitive cation channel 5, intestinal FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type III, beta FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type XI, alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type I, beta FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type 10, alpha polypeptide FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type IV, alpha polypeptide FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type V, alpha polypeptide FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type II, beta FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, nonvoltage-gated 1 alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, nonvoltage-gated 1 gamma FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, nonvoltage-gated 1 beta FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type XI, alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, nonvoltage-gated 1, gamma FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, nonvoltage-gated 1, delta FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, nonvoltage-gated 1 alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type X, alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type IX, alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage gated, type VIII, alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type VII, alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type IV, beta FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type IV, alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type III, alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type II, beta FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type II, alpha 2 FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type I, beta FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
sodium channel, voltage-gated, type I, alpha FLUPHENAZINE Sodium Channel, Site 2 100% 2.695uM 2.416uM View
nuclear receptor subfamily 3, group C, member 1 FLUOCINONIDE Glucocorticoid 100% .005263uM .002392uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 FLUPHENAZINE Dopamine Transporter 100% 2.053uM 1.631uM View
histamine receptor H 2 FLUPHENAZINE Histamine H2 100% 1.226uM 1.205uM View
5-hydroxytryptamine (serotonin) receptor 2A FLUPHENAZINE Serotonin 5-HT2A 100% .005104uM .001458uM View
adrenergic receptor, alpha 1a FLUPHENAZINE Adrenergic alpha1A 100% .024uM .009578uM View
adrenergic receptor, alpha 1b FLUPHENAZINE Adrenergic alpha1B 100% .034uM .019uM View
adrenergic receptor, alpha 2a FLUPHENAZINE Adrenergic alpha2A 100% .215uM .08uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 FLUPHENAZINE Adrenergic, Norepinephrine Transporter 100% 1.962uM 1.946uM View
dopamine receptor D3 FLUPHENAZINE Dopamine D3 100% .000594uM .000202uM View
sodium channel, voltage-gated, type IV, beta FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel associated protein 1 FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel associated protein 2 FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type III, beta FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type II, beta HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, nonvoltage-gated 1 alpha HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, nonvoltage-gated 1 gamma HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, nonvoltage-gated 1 beta HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage-gated, type XI, alpha HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, nonvoltage-gated 1, gamma HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, nonvoltage-gated 1, delta HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, nonvoltage-gated 1 alpha HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage-gated, type X, alpha HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage-gated, type IX, alpha HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage gated, type VIII, alpha HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage-gated, type VII, alpha HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage-gated, type IV, beta HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage-gated, type IV, alpha HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage-gated, type III, alpha HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage-gated, type II, beta HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage-gated, type II, alpha 2 HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage-gated, type I, beta HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
sodium channel, voltage-gated, type I, alpha HALOPERIDOL Sodium Channel, Site 2 100% .158uM .144uM View
adrenergic receptor, alpha 1b HALOPERIDOL Adrenergic alpha1B 100% .008935uM .004946uM View
adrenergic receptor, alpha 1a HALOPERIDOL Adrenergic alpha1A 100% .068uM .028uM View